Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2400181	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs	License Renew	2024-07-05					view
JYHZ2400180	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs	License Renew	2024-07-05					view
JYHZ2400179	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs	License Renew	2024-07-05					view
JYHZ2300410	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2023-10-31					view
JYHZ2300409	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2023-10-31					view
JYHZ2300408	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2023-10-31					view
JYHZ1900233	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs	License Renew	2019-09-02	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2020-05-09	view
JYHZ1900232	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs	License Renew	2019-09-02	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2020-05-09	view
JYHZ1900231	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs	License Renew	2019-09-02	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2020-05-09	view
JYHZ1900158	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2019-07-01	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2019-11-25	view
JYHZ1900157	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2019-07-01	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2019-11-25	view
JYHZ1800391	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2018-11-30	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2019-05-24	view
JYHZ1300226	羟萘酸沙美特罗	Salmeterol Hydroxynaphthoate	Active ingredient	Chemical Drugs	License Renew	2013-10-28	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	In Approval	2017-02-27	view
JYHS2400054	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs(5.2)	Import Drug Application	2024-10-30					view
JYHS2400053	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs(5.2)	Import Drug Application	2024-10-30					view
JYHS2300110	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs(5.2)	Import Drug Application	2023-08-29					view
JYHS2300109	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs(5.2)	Import Drug Application	2023-08-29					view
JYHS2300108	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs(5.2)	Import Drug Application	2023-08-29					view
JYHS2300024	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs(5.2)	Import Drug Application	2023-02-18					view
JYHS2300023	沙美特罗替卡松吸入粉雾剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs(5.2)	Import Drug Application	2023-02-18					view